Top Markets
#1 Siren Siren +34.00%
#2 OriginTrail OriginTrail +29.98%
#3 Waves Waves +14.16%
#4 BasedHype BasedHype +7.63%
#5 Pons Pons +7.39%
#6 MarsCoin MarsCoin +7.06%
#7 Arcium Arcium +6.31%
#8 Cysic Cysic +6.31%
#9 TROLL TROLL +6.06%
#10 PulseChain PulseChain +5.89%
Coin of the day
Siren Siren
설정
언어
한국어
통화
USD
테마
BRIM Biotechnology, Inc. BRIM Biotechnology, Inc.

BRIM Biotechnology, Inc.

6885
주식 순위 #22414
BRIM Biotechnology, Inc., a clinical-stage firm, specializes in developing... BRIM Biotechnology, Inc., a clinical-stage firm, specializes in developing innovative regenerative therapies to address both ophthalmic and degenerative joint conditions. Leading its pipeline is BRM 421, a topical ophthalmic solution designed to treat moderate-to-severe dry eye syndrome, which has successfully completed a Phase 2 clinical trial in the United States. The company's development efforts also encompass BRM 423, currently in Phase 1 clinical trials for severe corneal damage; BRM 424, also in Phase 1, targeting neurotrophic keratitis; and BRM 521, which aims to alleviate and repair tissue damage caused by osteoarthritis. Founded in 2013, BRIM Biotechnology is headquartered in Taipei, Taiwan.
주가
$0.66936954
마지막 동기화: 2026-07-28
시가총액
$89.04M
변동 (1일)
0.00%
변동 (1년)
-40.10%
국가
TW
거래 BRIM Biotechnology, Inc. (6885)

카테고리

Healthcare
BRIM Biotechnology, Inc. (6885)의 P/S 비율
2026 기준 P/S 비율 TTM: 0
BRIM Biotechnology, Inc.의 최신 재무 보고서와 주가에 따르면 현재 P/S 비율(TTM)은 0입니다. 2026년 말 기준 P/S 비율은 0였습니다.
BRIM Biotechnology, Inc.의 P/S 비율 기록 (2026 ~ 2026)
매년 말 P/S 비율
연도 P/S 비율 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 P/S 비율
회사 P/S 비율 P/S 비율 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH